SkinStim News
Leonhardt Ventures and Axolotl Biologix Announce Partnership to Study Combination Bioelectric and Biologic Therapies
Published May 19, 2018 | By Api Podder Partnership aims to build on synergies of bioelectric stimulation + amniotic fluid based regenerative fluids + re-fillable micro infusion pumps + mixed stem cell based compositions for candidate therapies to be studied for organ...
Leonhardt Adds HIF-1 Alpha To Estate of Bioelectric Controlled Release Regenerative Proteins
Press Release – Salt Lake City, Utah and Santa Monica, CA – June 8th, 2017 (PRBUZZ) — Leonhardt’s Launchpads, an organ regeneration and recovery focused innovation/startup accelerator today announced that it has filed a new patent application claim for the controlled...
BioLeonhardt Files Provisional Patent Application For Electrical Stimulation Controlled Release Of Follistatin
Published: Feb 18, 2016 Santa Monica, CA and Salt Lake City, Utah , Feb. 16th, 2015 /PRBuzz- BioLeonhardt MyoStimwww.bioleonhardt.com funded by Leonhardt Ventures a developer, manufacturer and marketer of advanced organ regeneration products focused on the heart and...
Leonhardt And Genovese File Patent For Bioelectric Controlled Expression Of PDGF A Powerful Organ Regeneration Cytokine
Published: Dec 20, 2016 Salt Lake City, Utah and Los Angeles, CA - December 19, 2016 (PRBUZZ) -- Leonhardt's Launchpads, an organ regeneration focused innovation/startup accelerator, focused on developing novel therapeutics for the treatment of organ degeneration...